SCHEMBL8302596

SCHEMBL8302596

C=S(=O)(c1ccc(OC)c(OC)c1)N(CC(=O)N/N=C/c1ccc(C(C)C)cc1)c1cc(Cl)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.60
HTT P42858 3/20 0.57
KMT2A Q03164 2/20 0.57
LMNA P02545 4/20 0.54
MAPT P10636 3/20 0.54
HPGD P15428 2/20 0.54
PKM P14618 1/20 0.51
CYP1A2 P05177 1/20 0.51
GLA P06280 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
ALDH1A1 P00352 2/20 0.49
ATM Q13315 1/20 0.49
KDM4E B2RXH2 3/20 0.48
HCRTR1 O43613 1/20 0.47
HCRTR2 O43614 1/20 0.47
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8300403 0.92 HTT (0.67) CASP6HTTKMT2ALMNAMAPT
SCHEMBL8299130 0.79 CASP6 (0.51) CASP6HTTKMT2ALMNAMAPT
SCHEMBL3364018 0.71 MAPT (0.62) KMT2ALMNAMAPTHPGDALDH1A1
SCHEMBL3364021 0.71 MAPT (0.62) KMT2ALMNAMAPTHPGDALDH1A1
SCHEMBL3366536 0.69 OXTR (0.74) KMT2ALMNAMAPTHPGDCYP3A4
SCHEMBL3369096 0.69 OXTR (0.74) KMT2ALMNAMAPTHPGDCYP3A4
SCHEMBL18958907 0.68 PKM (0.70) HTTKMT2ALMNAMAPTHPGD
SCHEMBL21033437 0.66 PKM (0.67) HTTKMT2ALMNAMAPTHPGD
SCHEMBL16557461 0.65 HPGD (0.69) KMT2ALMNAMAPTHPGDPKM
SCHEMBL18958914 0.65 PKM (0.68) HTTLMNAMAPTHPGDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037779-A2 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES IMTM GMBH (DE) 2005-04-28 WO disclosed